LIGAND PHARMACEUTICALS INCORPORATED
Patent Owner
Stats
- 44 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Aug 31, 2017 most recent publication
Details
- 44 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,317 Total Citation Count
- Dec 24, 1991 Earliest Filing
- 116 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2015/0071,857 STEROID HORMONE AND CHOLESTEROL PATHWAYS AS ONE UNIFIED HOMEOSTATIC SYSTEMMar 05, 13Mar 12, 15[A61K, G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9675583 Selective androgen receptor modulators (SARMS) and uses thereofAug 14, 15Jun 13, 17[A61K, C07D]
9676809 Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infectionsNov 19, 14Jun 13, 17[C07H]
9622991 Hematopoietic growth factor mimetic small molecule compounds and their usesMay 15, 15Apr 18, 17[A61K, C07D, C07C]
9492430 Methods and compositions associated with the granulocyte colony-stimulating factor receptorNov 12, 12Nov 15, 16[A61K, C12Q, C07D, A61N]
9359285 Androgen receptor modulator compounds and methodsOct 20, 14Jun 07, 16[A01N, C07F, C07D, C07C]
9144557 Hematopoietic growth factor mimetic small molecule compounds and their usesOct 12, 10Sep 29, 15[A61K, C07D, C07C]
9139520 Selective androgen receptor modulators (SARMs) and uses thereofApr 28, 14Sep 22, 15[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0356,325 NOVEL 2'-C-METHYL NUCLEOSIDE DERIVATIVE COMPOUNDSAbandonedJan 08, 13Dec 04, 14[C07H, A61K]
2014/0142,149 ORAL FORMULATIONS OF DIPHENYLSULFONAMIDE ENDOTHELIN AND ANGIOTENSIN II RECEPTOR AGONISTS TO TREAT ELEVATED BLOOD PRESSURE AND DIABETIC NEPHROPATHYAbandonedDec 19, 12May 22, 14[C07D]
2011/0224,153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related DisordersAbandonedApr 19, 10Sep 15, 11[A61K, A61P, C07K]
2011/0136,877 2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERSAbandonedJan 06, 09Jun 09, 11[A61K, C07D, C07C, A61P]
2011/0112,084 Bicyclic androgen and progesterone receptor modulator compounds and methodsAbandonedNov 13, 09May 12, 11[A61K, C07D, A61P]
2011/0082,130 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUESAbandonedAug 23, 10Apr 07, 11[A61K, C07D, A61P]
2010/0317,679 SUBSTITUTED ARYL-FUSED SPIROCYCLIC AMINESAbandonedSep 19, 08Dec 16, 10[A61K, C07D, G01N, A61P]
2010/0297,035 Thiazole Amides, Imidazole Amides and Related AnaloguesAbandonedApr 12, 10Nov 25, 10[A61K, C07D, G01N, A61P]
2010/0210,678 Tricyclic androgen receptor modulator compounds and methodsAbandonedMar 19, 10Aug 19, 10[A61K, C07D, A61P]
2010/0063,301 SYNTHESIS OF THROMBOPOIETIN ACTIVITY MODULATING COMPOUNDSAbandonedMar 14, 07Mar 11, 10[C07D]
7662819 Pteridinone derivatives for use as stearoyl CoA desaturase inhibitorsExpiredOct 05, 07Feb 16, 10[A61K, C07D, A61P]
2009/0281,075 ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORSAbandonedNov 07, 08Nov 12, 09[A61K, C07D, A61P]
2009/0227,571 Androgen Receptor Modulator Compounds and MethodsAbandonedJun 30, 06Sep 10, 09[A61K, C12Q, C12N, C07D, C07C]
2009/0203,725 Androgen Receptor Modulator Compounds and MethodsAbandonedDec 21, 06Aug 13, 09[A61K, C12N, C07D]
2009/0105,283 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSAbandonedOct 15, 08Apr 23, 09[A61K, C07D]
2009/0105,292 Glucocorticoid Receptor Modulator Compounds and MethodsAbandonedFeb 24, 05Apr 23, 09[A61K, C07D]
2008/0300,241 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methodsAbandonedNov 17, 06Dec 04, 08[A61K, C07D]
7442696 Mineralocorticoid receptor modulator compounds, processes for their preparation, and their usesExpiredJan 12, 07Oct 28, 08[C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
